New migraine drug tested in real patients shows promise
NCT ID NCT05903040
Summary
This study tested how well lasmiditan works to stop migraine attacks and what side effects people experienced when using it in their daily lives. Researchers followed 100 people with migraines who took lasmiditan tablets during at least four migraine attacks over three months. The goal was to see if this medication effectively relieves pain and allows people to return to normal activities within two hours.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
IRCCS National Neurological Institute "C. Mondino" Foundation
Pavia, 27100, Italy
-
SOD Centro Cefalee e Farmacologia Clinica, AOU Careggi
Florence, 50134, Italy
Conditions
Explore the condition pages connected to this study.